Home » NPS Pharmaceuticals Receives Notice From FDA for Gattex
NPS Pharmaceuticals Receives Notice From FDA for Gattex
NPS Pharmaceuticals announced that the FDA has notified the company that its NDA for Gattex (teduglutide) will be discussed at the Gastrointestinal Drugs Advisory Committee meeting scheduled for Oct. 16, 2012.
MarketWatch
MarketWatch
Upcoming Events
-
25Apr
-
07May
-
14May
-
30May